Characterization of an Krox-24/Egr-1-responsive element in the human tumor necrosis factor promoter.

[1]  A. Haese,et al.  Cooperation of GATA-1 and Sp1 can result in synergistic transcriptional activation or interference. , 1993, The Journal of biological chemistry.

[2]  E. Kutoh,et al.  Sp1 interacts with the consensus sequence for Egr-1 gene product with a cellular factor(s) and activates the transcription through this element. , 1993, Biochemical and biophysical research communications.

[3]  Y. Tan,et al.  Detection and characterization of cellular EGR-1 binding to its recognition site. , 1993, The Journal of biological chemistry.

[4]  V. Sukhatme,et al.  A novel repression module, an extensive activation domain, and a bipartite nuclear localization signal defined in the immediate-early transcription factor Egr-1 , 1993, Molecular and cellular biology.

[5]  Y. Sugiura,et al.  Binding of transcription factor Sp1 to GC box DNA revealed by footprinting analysis: different contact of three zinc fingers and sequence recognition mode. , 1993, Biochemistry.

[6]  J. Wagner,et al.  Nerve growth factor induces transcription of NGFIA through complex regulatory elements that are also sensitive to serum and phorbol 12-myristate 13-acetate. , 1993, Molecular endocrinology.

[7]  V. Sukhatme.  The Egr transcription factor family: from signal transduction to kidney differentiation. , 1992, Kidney international.

[8]  T. Shows,et al.  EGR3, a novel member of the Egr family of genes encoding immediate-early transcription factors. , 1991, Oncogene.

[9]  J. Baxter,et al.  Identification of a tumor necrosis factor-responsive element in the tumor necrosis factor alpha gene. , 1991, The Journal of biological chemistry.

[10]  V. Sukhatme,et al.  Early transcriptional events in cell growth: the Egr family. , 1990, Journal of the American Society of Nephrology : JASN.

[11]  H. Stunnenberg,et al.  The serum-inducible mouse gene Krox-24 encodes a sequence-specific transcriptional activator , 1990, Molecular and cellular biology.

[12]  T. Takishima,et al.  Gene expression and production of tumour necrosis factor by a rat basophilic leukaemia cell line (RBL-2H3) with IgE receptor triggering. , 1990, Immunology.

[13]  M. Vigneron,et al.  The segment‐specific gene Krox‐20 encodes a transcription factor with binding sites in the promoter region of the Hox‐1.4 gene. , 1990, The EMBO journal.

[14]  Jiahuai Han,et al.  Endotoxin-responsive sequences control cachectin/tumor necrosis factor biosynthesis at the translational level [published erratum appears in J Exp Med 1990 Mar 1;171(3):971-2] , 1990, The Journal of experimental medicine.

[15]  G. A. Limb,et al.  Release of cytokines during generation of lymphokine-activated killer (LAK) cells by IL-2. , 1989, Immunology.

[16]  D. Morton,et al.  Genetic analysis of the human tumor necrosis factor alpha/cachectin promoter region in a macrophage cell line , 1989, The Journal of experimental medicine.

[17]  M. Turner,et al.  Modulation of cytokine production by transforming growth factor-beta. , 1989, Journal of immunology.

[18]  D. Morton,et al.  IL-4 down-regulates IL-1 and TNF gene expression in human monocytes. , 1989, Journal of immunology.

[19]  C. Tannenbaum,et al.  Lipopolysaccharide-induced gene expression in murine peritoneal macrophages is selectively suppressed by agents that elevate intracellular cAMP. , 1989, Journal of immunology.

[20]  K. Tracey,et al.  Cachectin/tumor necrosis factor and other cytokines in infectious disease. , 1989, Current opinion in immunology.

[21]  P. Scheurich,et al.  Tumor necrosis factor and lymphotoxin gene expression in human tumor cell lines. , 1988, Cancer research.

[22]  C. Perez,et al.  A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: Ramifications for the complex physiology of TNF , 1988, Cell.

[23]  K. Tracey,et al.  Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation , 1988, The Journal of experimental medicine.

[24]  Robert Tjian,et al.  Isolation of cDNA encoding transcription factor Sp1 and functional analysis of the DNA binding domain , 1987, Cell.

[25]  P. Vassalli,et al.  Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease , 1987, The Journal of experimental medicine.

[26]  G. Trinchieri,et al.  Independent regulation of tumor necrosis factor and lymphotoxin production by human peripheral blood lymphocytes , 1987, The Journal of experimental medicine.

[27]  D. Belin,et al.  Gamma interferon enhances macrophage transcription of the tumor necrosis factor/cachectin, interleukin 1, and urokinase genes, which are controlled by short-lived repressors , 1986, The Journal of experimental medicine.

[28]  B. Beutler,et al.  Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. , 1986, Science.

[29]  B. Beutler,et al.  Cachectin and tumour necrosis factor as two sides of the same biological coin , 1986, Nature.

[30]  L. Old,et al.  Tumor necrosis factor (TNF). , 1985, Science.

[31]  R. Tjian,et al.  Sp1 binds to promoter sequences and activates herpes simplex virus ‘immediate-early’ gene transcription in vitro , 1985, Nature.

[32]  D. Goeddel,et al.  Human lymphotoxin and tumor necrosis factor genes: structure, homology and chromosomal localization. , 1985, Nucleic acids research.

[33]  P. Charnay,et al.  Difference in the genomic organizations of the related transcription factors Sp1 and Krox-20; possible evolutionary significance. , 1992, DNA sequence : the journal of DNA sequencing and mapping.

[34]  S. Deutsch,et al.  Genomic structure, induction, and production of TNF-alpha. , 1992, Immunology series.

[35]  A. Fauci,et al.  Immunopathogenic mechanisms of HIV infection: cytokine induction of HIV expression. , 1990, Immunology today.

[36]  K. Pfizenmaier,et al.  PMA-responsive 5' flanking sequences of the human TNF gene. , 1989, Lymphokine research.

[37]  D. Männel,et al.  Autocrine stimulation of TNF-alpha mRNA expression in HL-60 cells. , 1987, Lymphokine research.

[38]  W. Gilbert,et al.  Sequencing end-labeled DNA with base-specific chemical cleavages. , 1980, Methods in enzymology.